Effects of epidermal growth factor, transferrin, and insulin on lipofection efficiency in human lung carcinoma cells

Cancer Gene Therapy

Volumn 7, Issue 1, 2000, Pages 59-65

  Yanagihara, Katsunori ^a   Cheng, Helen ^a   Cheng, Pi Wan ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Gene therapy; Gene transfer; Ligand; Lipofection; Liposome; Nonviral vector

Indexed keywords

BETA GALACTOSIDASE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; INSULIN; LIPOFECTIN; PLASMID DNA; TRANSFERRIN;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DNA TRANSFECTION; ENZYME ACTIVITY; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRAIN DIFFERENCE;

EID: 0033953383     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700092     Document Type: Article

References (34)

1. Hammar SP. In: Hammar SP, ed. Pulmonary Pathology. New York: Springer Verlag; 1988:727-845.
2. Landis SH, Murray T, Bolden S, et al. Cancer statistics, 1998. CA Cancer J Clin. 1998;48:6-29.
3. Morgan JR, Tompkins RG, Yarmush ML. Advances in recombinant retroviruses for gene delivery. Adv Drug Delivery Rev. 1993;12:143-158.
4. Colledge WH. Cystic fibrosis gene therapy. Curr Opin Genet Dev. 1994;4:466-471.
5. Olsen JC, Huang W, Johnson LG, et al. Persistent adenoviral vector gene expression in CF airway cells is due to integration of vector sequences into chromosomal DNA. Pediatr Pulmonol. 1994;S10:230.
6. Gotten M, Wagner E. Non-viral approaches to gene therapy. Curr Opin Biotechnol. 1993;4:705-710.
7. Ledley FD. Nonviral gene therapy. Curr Opin Biotechnol. 1994;5:626-636.
8. Yei S, Mittereder N, Tany K, et al. Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung. Gene Ther. 1991;1:192-200.
9. Yang Y, Nunes FA, Berencsi K, et al. Cellular immunity to viral antigen limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA. 1994;91:4407-4411.
10. Trapnell BC, Gorziglia M. Gene therapy using adenoviral vectors. Curr Opin Biotechnol. 1994;5:617-625.
11. Ponnazhagan S, Erikson D, Kearns WG, et al. Lack of site-specific integration of the recombinant adeno-associated virus 2 genomes in human cells. Hum Gene Ther. 1997;8:275-284.
12. Fairbairn LJ, Cross MA, Arrand JR. Paterson symposium 1993: gene therapy. Br J Cancer. 1994;59:972-975.
13. Russel DW, Miller AD, Alexander IE. Adeno-associated virus vectors preferentially transduce cells in S phase. Proc Natl Acad Sci USA. 1994;91:8915-8919.
14. Wu GY, Wu CH. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J Biol Chem. 1987;262:4429-4432.
15. Yin W, Cheng P-W. Lectin conjugate-directed gene transfer to airway epithelial cells. Biochem Biophys Res Commun. 1994;205:826-833.
16. Kikuchi A, Sugaya S, Ueda H, et al. Efficient gene transfer to EGF receptor-overexpressing cancer cells by means of EGF-labeled cationic liposomes. Biochem Biophys Res Commun. 1996:666-671.
17. Hara T, Kuwasawa H, Aramaki Y, et al. Effects of fusogenic and DNA-binding amphiphilic compounds on the receptor-mediated gene transfer into hepatic cells by asialofetuin-labeled liposomes. Biochim Biophys Acta. 1996;1278:51-58.
18. Felgner JH, Gadek TR, Holm M, et al. Lipofectin: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA. 1987;84:7413-7417.
19. Zhou X, Huang L. DNA transfection mediated by cationic liposomes containing lipopolylysine: characterization and mechanism of action. Biochim Biophys Acta. 1994;1189: 195-203.
20. Hoganson DK, Chandler LA, Fleurbaaij GA, et al. Targeted delivery of DNA encoding cytotoxic proteins through high-affinity fibroblast growth factor receptors. Hum Gene Ther. 1998;9:2565-2575.
21. Namiki Y, Takahashi T, Ohno T. Gene transduction for disseminated intraperitoneal tumor using cationic liposomes containing non-histone chromatin proteins: cationic liposomal gene therapy of carcinomatosa. Gene Ther. 1998;5:240-246.
22. Cheng P-W. Receptor ligand-facilitated gene transfer: enhancement of liposome-mediated gene transfer and expression by transferrin. Hum Gene Ther. 1996;7:275-282.
23. Cheng P-W, Johnson L. Restoration of the chloride transport properties of CFT1 cells by insulin-facilitated gene transfer. Am J Respir Crit Care Med. 1996;153:A114.
24. Xu L, Pirollo KF, Chang EH. Transferrin-liposome-mediated p53 sensitization of a squamous cell carcinoma of the head and neck to radiation in vitro. Hum Gene Ther. 1997;8:467-475.
25. Hagstrom JE, Sebestyen MG, Budker V, et al. Complexes of non-cationic liposomes and histone H1 mediate efficient transfection of DNA without encapsulation. Biochim Biophys Acta. 1996;1284:47-55.
26. Hunter T. The epidermal growth factor receptor gene and its product. Nature. 1984;311:414-416.
27. Veale D, Ashcroft T, Marsh C, et al. Epidermal growth factor receptors in non-small cell lung cancer. Br J Cancer. 1987;55:513-516.
28. Veale D, Kerr N, Gibson GJ, et al. Characterization of epidermal growth factor receptor in primary human non-small cell lung cancer. Cancer Res. 1989;49:1313-1317.
29. Chen J, Gamou S, Takayanagi A, et al. A novel gene delivery system using EGF receptor-mediated endocytosis. FEBS Lett. 1994;338:167-169.
30. Cristiano RJ, Roth JA. Epidermal growth factor-mediated DNA delivery into lung cancer via the epidermal growth factor receptor. Cancer Gene Ther. 1994;3:4-10.
31. Ferkol T, Pellicena-Palle A, Eckamn E, et al. Immunologic response to gene transfer into mice via the polymeric immunoglobulin receptor. Gene Ther. 1996;3:669-678.
32. Thomas DA, Myers MA, Wichert B, et al. Acute effects of liposome aerosol inhalation on pulmonary function in healthy human volunteers. Chest. 1991;99:1268-1270.
33. Alton EWFW, Middleton OG, Caplen NJ, et al. Noninvasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice. Nat Genet. 1993;5:135-142.
34. San H, Yang ZY, Pompili VJ, et al. Safety and short term toxicity of a novel cationic lipid formulation human gene therapy. Hum Gene Ther. 1993;4:781-788.